ArticleThe Lancet. Infectious diseases2022

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.

Daniel J Sheward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.